NCT04716335View on ClinicalTrials.gov

Neurodynamics of Prosocial Emotional Processing Following Serotonergic Stimulation With N,N-Dimethyltryptamine (DMT) and Harmine in Healthy Subjects

EARLY_PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 1, 2020

Primary Completion Date

July 19, 2021

Study Completion Date

January 10, 2022

Conditions

EmotionsMoodCognitive Function 1, SocialEmpathy

Interventions

DRUG

DMT

DRUG

Harmine

DRUG

Placebo (Harmine)

Placebo for Harmine

DRUG

Placebo (DMT)

Placebo for DMT

Trial Locations (1)

8032

Psychiatric University Hospital, Zurich

All Listed Sponsors

collaborator

University of Basel

OTHER

lead

Psychiatric University Hospital, Zurich

OTHER

NCT04716335 - Neurodynamics of Prosocial Emotional Processing Following Serotonergic Stimulation With N,N-Dimethyltryptamine (DMT) and Harmine in Healthy Subjects | Biotech Hunter | Biotech Hunter